← Leaderboards
Susan K. Logan
New York University School Of Medicine
$6,042,583
Attributed
$6,042,583
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $704.9K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,042,583 · 3
By mechanism
R01$5,612,391 · 2
R21$430,192 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Nicholas Cowan$7,165,268
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateResistanceAndrogen ReceptorGenetic TranscriptionGenomicsTherapy ResistantProteinsAndrogensAffectProstateIn VivoGenesMediatingComplexCell GrowthTumor ProgressionGrantPrefoldinPlayAblationRegulationMessenger RnaRegulator GenesDisease Progression
Grant awards (19)
Macrocycle inhibition of beta-catenin mediated transcription in prostate cancer$684,075
R01 · FY2025 · CA · contact PI
Macrocycle inhibition of beta-catenin mediated transcription in prostate cancer$704,918
R01 · FY2024 · CA · contact PI
Suppression of Prostate Cancer$194,142
R21 · FY2023 · CA · contact PI
Suppression of Prostate Cancer$236,050
R21 · FY2022 · CA · contact PI
Transcription repression in prostate cancer$390,486
R01 · FY2019 · CA · contact PI
Transcription repression in prostate cancer$5,987
R01 · FY2019 · CA · contact PI
Transcription repression in prostate cancer$402,563
R01 · FY2018 · CA · contact PI
Transcription repression in prostate cancer$80,838
R01 · FY2018 · CA · contact PI
Transcription repression in prostate cancer$402,563
R01 · FY2017 · CA · contact PI
Transcription repression in prostate cancer$80,838
R01 · FY2017 · CA · contact PI
Transcription repression in prostate cancer$402,563
R01 · FY2016 · CA · contact PI
Transcription repression in prostate cancer$61,664
R01 · FY2016 · CA · contact PI
Transcription repression in prostate cancer$402,563
R01 · FY2015 · CA · contact PI
An androgen receptor coactivator regulated in prostate$255,872
R01 · FY2014 · CA · contact PI
An androgen receptor coactivator regulated in prostate$341,161
R01 · FY2012 · CA · contact PI
An androgen receptor coactivator regulated in prostate$341,161
R01 · FY2011 · CA · contact PI
An androgen receptor coactivator regulated in prostate$351,713
R01 · FY2010 · CA · contact PI
An androgen receptor coactivator regulated in prostate$351,713
R01 · FY2009 · CA · contact PI
An androgen receptor coactivator regulated in prostate$351,713
R01 · FY2008 · CA · contact PI